Vault-13

INOTEK PHARMACEUTICALS CORP RCKT 5.75 08.01.21

NOTE 5.750% 8/0 · US DOMESTIC · CUSIP 45780VAB8

9 institutional holders
$57.1mprincipal reported held*
$55.0mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($8.0m this quarter). Holder counts are more reliable.

Holders, Q4 2019

#ManagerLocationShares Value% of their portfolioChangeShares change
1 DeepCurrents Investment Group LLC 0.91% of their portfolio NEW YORK, NY 18,100,00018.1m $19.9m $19.9m 0.91% —
2 CITADEL ADVISORS LLC 0.02% of their portfolio MIAMI, FL 14,750,00014.8m $16.7m $16.7m 0.02% —
3 WOLVERINE ASSET MANAGEMENT LLC 0.15% of their portfolio CHICAGO, IL 7,500,0007.5m $8.2m $8.2m 0.15% —
4 Verition Fund Management LLC 0.25% of their portfolio GREENWICH, CT 7,300,0007.3m $8.0m $8.0m 0.25% —
5 DEUTSCHE BANK AG\ 0.00% of their portfolio FRANKFURT AM MAIN, 2M 4,000,0004.0m $4.3m $4.3m 0.00% —
6 CREDIT SUISSE AG/ 0.00% of their portfolio ZURICH, V8 2,500,0002.5m $2.7m $2.7m 0.00% —
7 Bruce & Co., Inc. 0.43% of their portfolio CHICAGO, IL 2,000,0002.0m $2.2m $2.2m 0.43% —
8 Tetragon Partners GP Ltd 0.16% of their portfolio GRAND CAYMAN, E9 1,000,0001.0m $1.1m $1.1m 0.16% —
9 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% —